Membrane damage model of lipid peroxidation, using carboxyfluorescein enveloping liposome
使用羧基荧光素包封脂质体的脂质过氧化膜损伤模型
基本信息
- 批准号:04670208
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1992
- 资助国家:日本
- 起止时间:1992 至 1993
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A Carboxyfluorescein (CF) -enveloping liposome is presented as a physicochemical damage model of the biomembrane for the study of lipid peroxidation. The degree of membrane damage may be assessed by measurement of the fluorescence intensity of CF released from damaged liposomes after the interaction between the liposomal membrane and a radical initiator. The process of lipid peroxidation was biochemically confirmed by the thiobarbituric acidreactive substances (TBARS) test done simultaneously. Three types of CF-enveloping liposomes, i.e., soybean phosphatidylcholine (SPC) containing polyunsaturated fatty acid, dipalmitoylphosphatidylcholine (DPPC) containing saturated fatty acid, and soybean phosphatidylcholine plus alpha-tocopherol, were exposed to a known radical initiator, ferric nitrilotriacetate with a reductant (either cysteine, reduced form glutathione, or ascorbic acid). The release of CF from the peroxidized liposome was measured with a fluorospectrophotometer. A high release of CF and a high level of TBARS were seen in the SPC liposomes, but not in the DPPC and alpha-tocopherol-inserted SPC liposomes. This liposome model is superior to the conventional red cell hemolysis model for several reasons : (1) the constituents of the membrane are defined ; (2) CF is not a radical initiator, whereas hemoglobin is a potential radical initiator ; and (3) the membrane components can be easily changed depending on the purpose of the experiment.
为了研究脂质过氧化作用,提出了一种包裹羧基荧光素(CF)的脂质体作为生物膜的物理化学损伤模型。膜损伤的程度可以通过测量脂膜与自由基引发剂相互作用后从受损脂质体释放的CF的荧光强度来评估。同时进行硫代巴比妥酸反应物质(TBARS)检测,以生化方法证实脂质过氧化过程。将含多不饱和脂肪酸的大豆磷脂酰胆碱(SPC)、含饱和脂肪酸的二棕榈酰磷脂酰胆碱(DPPC)和大豆磷脂酰胆碱+α-生育酚三种类型的CF包膜脂质体暴露于已知的自由基引发剂--含有还原剂(半胱氨酸、还原型谷胱甘肽或抗坏血酸)的氮三乙酸铁。用荧光分光光度计法测定过氧化脂质体释放量。SPC脂质体有较高的CF释放量和较高的TBARS释放量,而DPPC脂质体和α-生育酚SPC脂质体则无此现象。这种脂质体模型优于传统的红细胞溶血模型,原因如下:(1)定义了膜的组成;(2)CF不是自由基引发剂,而血红蛋白是潜在的自由基引发剂;(3)根据实验目的,膜成分可以很容易地改变。
项目成果
期刊论文数量(46)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ying-yan Yu, Tetsuya Ogino, Shigeru Okada: "Histochemical detection of lipid peroxidation in human gastrointestinal, mammary and renal carcinomas." Acta Med.Okayama. 46. 233-239 (1992)
Ying-yan Yu、Tetsuya Ogino、Shigeru Okada:“人类胃肠癌、乳腺癌和肾癌中脂质过氧化的组织化学检测。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Daxian Zhang, Tatsuji Yasuda, Shigeru Okada: "A carboxyfluorescein - enveloping liposome as a physicochemical damage model of the biomembrane for the study of lipid peroxidation." J.Clin.Biochem.Nutr.14. 83-90 (1993)
Daxian Zhang、Tatsuji Yasuda、Shigeru Okada:“一种羧基荧光素 - 包封脂质体作为生物膜的理化损伤模型,用于研究脂质过氧化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Teruyuki Kawabata, Shigeru Okada, Miao Liu, Akira Asaumi, Takashi Akiyama: "Action of pyridinecarboxamides on Fe(III)-NTA induced renal toxicity and superoxide anion." Oxygen Radicals.Ed.K.Yagi, M.Kondo, E.Niki and T.Yoshikawa, Elsevier Science Publishers
Teruyuki Kawabata、Shigeru Okada、Miao Liu、Akira Asaumi、Takashi Akiyama:“吡啶甲酰胺对 Fe(III)-NTA 诱导的肾毒性和超氧阴离子的作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Kawabata,S.Okada, T.Akiyama,A.Asaumi: "Generation of Superoxide Anion in Fe(III)-nta(nta=nitrilotriacetate) and H_2O_2 System. An ESR Study." Chemistry Letters. 2189-2192 (1992)
T.Kawabata,S.Okada, T.Akiyama,A.Asaumi:“Fe(III)-nta(nta=次氮基三乙酸盐) 和 H_2O_2 系统中超氧阴离子的生成。ESR 研究。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Daxian Zhang: "A carboxyfluorescein-enveloping liposome as a physicochemical damage model of the biomembrane for the study of lipid peroxidation." J.Clin.Biochem.Nutr.14. 83-90 (1993)
张大贤:“一种羧基荧光素包封的脂质体作为生物膜的理化损伤模型,用于研究脂质过氧化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKADA Shigeru其他文献
OKADA Shigeru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKADA Shigeru', 18)}}的其他基金
Studies on the mechanisms for biosynthesis of useful hydrocarbons by a green microalga based on data from EST analyses.
基于 EST 分析数据研究绿色微藻生物合成有用碳氢化合物的机制。
- 批准号:
21380130 - 财政年份:2009
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Preparation of sodium contained aluminum higher borides and a search of higher hardness material
含钠铝高硼化物的制备及高硬度材料的探索
- 批准号:
20560629 - 财政年份:2008
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on enzymes concerned in the biosynthesis of large amounts of useful isoprenoids by a green microalga
绿色微藻生物合成大量有用类异戊二烯所涉及的酶的研究
- 批准号:
18580202 - 财政年份:2006
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on enzyme activities for useful isoprenoid biosynthesis in a microalga.
微藻中有用类异戊二烯生物合成的酶活性研究。
- 批准号:
16580166 - 财政年份:2004
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hepatocarcinogenetic Studies in Myanmar Thalassemiacs
缅甸地中海贫血患者的肝癌发生研究
- 批准号:
08042005 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for international Scientific Research
Hybrization of deciduous Quercus species in Chugoku Mountain
中国山落叶栎树种的杂交
- 批准号:
04806021 - 财政年份:1992
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
TREATMENT OF WASTE SOLUTIONS BY USE OF ORGANICLIQUIDS PARTIALLY MISCIBLE WITH WATER.
使用与水部分混溶的有机液体处理废物溶液。
- 批准号:
61550462 - 财政年份:1986
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
Microbubble-ZPDGFRβ/PFD/liposome通过靶向肝星状细胞改善肿瘤微环境抑制肝细胞癌复发转移的作用及机制研究
- 批准号:82272000
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于Gd-HPDO3A@Liposome-Ga-68的PET/MR用于肝肿瘤增强显像及酸碱微环境检测
- 批准号:81701761
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Exploring ATR and PARP Inhibitors for Ovarian Cancer Management: An Innovative Approach
探索 ATR 和 PARP 抑制剂用于卵巢癌治疗:一种创新方法
- 批准号:
494635 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Operating Grants
A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy
用于改进结直肠癌免疫化疗的磷脂衍生纳米治疗平台
- 批准号:
10658146 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Combination of tumor targeted therapy with stroma modulating agent for PDAC
肿瘤靶向治疗与基质调节剂联合治疗 PDAC
- 批准号:
10629924 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Customized nanofibers with preferential lung-targeting properties for treating metastatic pulmonary tumors
具有优先肺部靶向特性的定制纳米纤维可用于治疗转移性肺肿瘤
- 批准号:
10623913 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Novel discovery of the antibody conjugated liposome for RAS/BRAF mutated colorectal and pancreatic cancers
针对 RAS/BRAF 突变结直肠癌和胰腺癌的抗体偶联脂质体的新发现
- 批准号:
23K15080 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Developing a combinatorial treatment of CAR-T therapy and liposome-based mRNA vaccination for pediatric solid tumors
开发针对儿科实体瘤的 CAR-T 疗法和基于脂质体的 mRNA 疫苗接种的组合疗法
- 批准号:
23K07247 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Project 2: Inhibiting AXL to Improve Treatment Response in Endometrial Cancer
项目2:抑制AXL以改善子宫内膜癌的治疗反应
- 批准号:
10711637 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Liposome fusion enabled extracellular vesicle detection for COVID-19
脂质体融合实现了 COVID-19 的细胞外囊泡检测
- 批准号:
10528030 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别: